COCRYSTAL PHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
COCRYSTAL PHARMA, INC. (COCP) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $4.99 per share as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $4.99.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $6.10.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $8.91.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $8.91.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $4.99 10-Q · filed 2026-08-13 |
| 2026-03-31 | $6.10 10-Q · filed 2026-05-15 |
| 2025-09-30 | $8.91 10-Q · filed 2025-11-14 |
| 2025-06-30 | $8.91 10-Q · filed 2025-08-14 |
| 2025-03-31 | $10.39 10-Q · filed 2025-05-15 |
| 2024-12-31 | $10.37 10-K · filed 2025-03-31 |
| 2024-09-30 | $10.40 10-Q · filed 2024-11-13 |
| 2024-06-30 | $10.40 10-Q · filed 2024-08-14 |
| 2024-03-31 | $10.38 10-Q · filed 2024-05-13 |
| 2023-12-31 | $10.38 10-K · filed 2024-03-28 |
| 2023-09-30 | $10.37 10-Q · filed 2023-11-13 |
| 2023-06-30 | $14.98 10-Q · filed 2023-08-14 |
| 2023-03-31 | $14.98 10-Q · filed 2023-05-15 |
| 2022-12-31 | $14.98 10-K · filed 2023-03-29 |
| 2022-09-30 | $15.12 10-Q · filed 2022-11-14 |
| 2021-12-31 | $1.98 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |